PODD Dec 2024 230.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

15.30

0.00

(0.00%)

As of 10:57AM EDT. Market open.

Loading interactive chart…

Zacks
Is Insulet (PODD) Stock an Apt Pick for Your Portfolio Now?
The robust performance of Insulet's (PODD) Omnipod 5 raises investors' optimism. However, concerns remain over the macroeconomic impacts and the company's overdependence on a single platform.
GuruFocus.com
Insider Sale: Director Timothy Scannell Sells 7,000 Shares of Insulet Corp (PODD)
Director Timothy Scannell of Insulet Corp (NASDAQ:PODD) sold 7,000 shares of the company on June 10, 2024, according to a recent SEC Filing.
Business Wire
Insulet to Present at the Jefferies Global Healthcare Conference
ACTON, Mass., May 28, 2024--Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at the Jefferies Global Healthcare Conference in New York City on Thursday, June 6, 2024 at 9:00 a.m. (Eastern Time).